Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
SPECTRA is a research initiative to identify and act on autism trajectories—the evolving developmental paths individuals follow from prenatal through aging—including autism characteristics, co-occurring conditions, functional outcomes, and the genetic, biological, behavioral, iatrogenic, and environmental factors that interact nonlinearly over time. Rather than studying these factors in isolation, it will examine how they combine and interact to produce autism and co-occurring conditions. SPECTRA will also develop dual-purpose technologies that extend reliable assessment beyond the clinic while improving everyday communication, function, and quality of life, with the same tools generating data for measurement and personalized care. Amendment 2, dated 10/29/2026, adds ISO updates across Parts I, II, III, and VI; TA1/TA2/TA4 clarifications and updates; a Q&A link; and attachments covering TA4 proposal requirements/templates and TA1/TA2 solution summary requirements.